Cell-based medicine is moving from experimental clinics to commercial-scale production, and the manufacturing backbone behind it is straining to keep pace. According to Polaris Market Research, the global cell therapy manufacturing market was valued at USD 5.68 Billion in 2024 and is projected to reach USD 24.18 Billion by 2034, growing at a CAGR of 15.6%. The Shift: What's Actually Changing...